Lauren Postlewait
Overview
Dr. Lauren Postlewait is a specialist in breast cancer surgery and the treatment of breast disease. Her clinical interests include providing comprehensive, multidisciplinary care for patients with breast cancer. Her practice is based primarily at Grady Memorial Hospital.
She received her MD at Emory University School of Medicine in 2012. She remained at Emory and completed her clinical residency in general surgery and a two-year research fellowship in surgical oncology, after which she completed a clinical fellowship in breast surgical oncology at the University of Texas MD Anderson Cancer Center in Houston.
Dr. Postlewait has a variety of research interests. She has worked in clinical investigation and outcomes analysis of patients treated for advanced and inflammatory breast cancer. She is also interested in optimizing the treatment of breast cancer patients through improving patient education techniques and investigating appropriate de-escalation of surgical techniques to reduce morbidity while maintaining excellent outcomes in the context of multidisciplinary care. In addition, she has a passion for clinical ethics as well as identifying and improving health disparities.
She has received numerous awards for her research including the Merit Award in 2015 and 2016 from the Conquer Cancer Foundation of the American Society of Clinical Oncology as well as Best Clinical Research awards at Emory Department of Surgery Research Days in 2015 and 2017.
Academic Appointment
- Assistant Professor of Surgery, Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine
Education
Degrees
- Breast Surgical Oncology Fellowship from University of Texas MD Anderson Cancer Center
- General Surgery Residency from Emory University School of Medicine
- Research Sabbatical, Surgical Oncology (mentor: Shishir Maithel, MD) from Emory University School of Medicine
- General Surgery Residency from Emory University School of Medicine
- MD from Emory University School of Medicine
Research
Publications
-
Postmastectomy Radiation Therapy for Intermediate-Risk Breast Cancer Patients With 0-3 Positive Axillary Lymph Nodes: Emulating the SUPREMO Trial Using Real-World Data.
Clin Breast Cancer Volume: 25 Page(s): e655 - e665.e4
07/01/2025 Authors: Kulkarni SE; Patel SA; Jiang C; Schwieger L; Postlewait LM; Arciero CA; Gillespie TW; Liu Y -
The prevalence and clinical significance of residual occult breast cancer after neoadjuvant chemotherapy: reassessing surgical pathology in cases initially described as pathological complete response.
Histopathology Volume: 86 Page(s): 1112 - 1120
06/01/2025 Authors: Ai D; Arrey EN; Postlewait LM; Gao Y; Li X -
A Multi-institutional Study From the US Resident Operative Experience Consortium Examining Factors Associated With Exposure and Pursuit of Colorectal Fellowship After General Surgery Residency.
Dis Colon Rectum Volume: 68 Page(s): 637 - 646
05/01/2025 Authors: Price AD; Nasim BW; Montgomery KB; Layne DL; Cortez AR; Abelson JS; Patel JA; US Resident OPerative Experience (ROPE) Consortium -
ASO Author Reflections: Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
Ann Surg Oncol Volume: 31 Page(s): 8910 - 8911
12/01/2024 Authors: Cheng O; Postlewait LM -
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
Ann Surg Oncol Volume: 31 Page(s): 7249 - 7259
10/01/2024 Authors: Switalla KM; Boughey JC; Dimitroff K; Yau C; Ladores V; Yu H; Tchou J; Golshan M; Ahrendt G; Postlewait LM -
Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.
Ann Surg Oncol Volume: 31 Page(s): 7420 - 7428
10/01/2024 Authors: Piltin MA; Norwood P; Ladores V; Mukhtar RA; Sauder CA; Golshan M; Tchou J; Rao R; Lee MC; Son J -
Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
Ann Surg Oncol Volume: 31 Page(s): 7570 - 7581
10/01/2024 Authors: Cheng O; Fiser C; Paysour J; Aluwalia R; Hilliard A; Arciero C; Farley CR; Jones J; Conyers J; Postlewait LM -
Changes in expression of breast cancer tumor biomarkers between primary tumors and corresponding metastatic sites: common patterns and relationships with survival.
Breast Cancer Res Treat Volume: 207 Page(s): 373 - 382
09/01/2024 Authors: Schwieger L; Postlewait LM; Liu Y; Jou S; Yi S; Peng L; Li X -
ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
Ann Surg Oncol
08/13/2024 Authors: Switalla KM; Boughey JC; Dimitroff K; Yau C; Ladores V; Yu H; Tchou J; Golshan M; Ahrendt G; Postlewait LM -
ASO Visual Abstract: Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy-Results from the I-SPY2 Clinical Trial.
Ann Surg Oncol
08/03/2024 Authors: Piltin MA; Norwood P; Ladores V; Mukhtar RA; Sauder CA; Golshan M; Tchou J; Rao R; Lee MC; Son J